As per the Revvity Signals Product Life Cycle, Tibco Spotfire Clinical Graphics (TSCG) has entered the Sunset phase, effective June 16th 2017. Unless otherwise provided, the Sunset phase shall end one (1) year from the effective date immediately above. On June 15th 2018, TSCG will reach End of Life (“EOL”). During the Sunset phase, we will continue to provide limited support to each Customer with an active maintenance for this Product, as described in the Product Life Cycle. Except for the support options described in the Revvity Signals Product Life Cycle, once EOL is reached Revvity Signals will no longer provide support for these products.
Customers are encouraged to contact Professional Services for scoping a project to generate clinical graphics objects leveraging Spotfire and its TERR/R integration.